ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AGY Allergy Therapeutics Plc

2.90
0.00 (0.00%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allergy Therapeutics Plc LSE:AGY London Ordinary Share GB00B02LCQ05 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.90 2.80 3.00 2.95 2.90 2.90 782,547 08:35:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 59.59M -43.07M -0.0090 -3.22 138.23M
Allergy Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker AGY. The last closing price for Allergy Therapeutics was 2.90p. Over the last year, Allergy Therapeutics shares have traded in a share price range of 0.85p to 3.80p.

Allergy Therapeutics currently has 4,766,439,938 shares in issue. The market capitalisation of Allergy Therapeutics is £138.23 million. Allergy Therapeutics has a price to earnings ratio (PE ratio) of -3.22.

Allergy Therapeutics Share Discussion Threads

Showing 2651 to 2675 of 5000 messages
Chat Pages: Latest  116  115  114  113  112  111  110  109  108  107  106  105  Older
DateSubjectAuthorDiscuss
02/4/2014
20:13
RNS says they hold 25%......

Total (A+B+C)
Number of voting rights Percentage of voting rights
-----------------------------------------------------------------------
103,457,784 25.24%

audigger
02/4/2014
20:09
Rule 9 of the takeover code states any investor holding 29.9% or above is obliged to make an offer for the company.
barefoot141
02/4/2014
19:53
Think it's 33.7% but not sure it triggers a bid?
cube boss
02/4/2014
19:10
Hi Jimmy, Southern Fox / Chase Nom is an Investment company
When it says Crossed or Reached, it means have they added or sold! in this case they have added around 1.25 mill, They added around 3/4 weeks ago if you look back, a similar RNS came out then!
They have been adding for the last few years.
Every time a company adds or sells, if they hold over 3%, then the mentioned Company have to publish an RNS.
If a company holds, I think it's 33% then they can make a bid for the company, but I think they are adding for their investors as they see value in AGY.
Will check on the % and get back soon..:0)

cube boss
02/4/2014
18:10
Cube et al, can you explain for me and the masses what this RNS means please

What stake triggers a bid?

jimmyloser
02/4/2014
15:26
A little positive news from yesterday:

Allergy Therapeutics plc (LON:AGY) had its target price boosted by Panmure Gordon from GBX 16 ($0.27) to GBX 25 ($0.42). The firm currently has a buy rating on the stock.

FG

farmer george
02/4/2014
11:45
Well, it's the long game we are in for and any positive news flow will move the share price up sharply IMHO.

FG

farmer george
02/4/2014
11:26
Looks like the seller is out, think someone is taking all sells! Max buy is 37k online..:0)
cube boss
02/4/2014
09:29
Not looking good Barefoot, nothing has changed guys! amazing how a few small trades takes us down 7/8%. Time for a dog walk me thinks...:0)
cube boss
01/4/2014
18:45
Ah the ole 62% fib retrace bounce. I bloody hope so as another not to be mentioned on this thread biotech company is near this point as well. If wrong i'm surrender......
barefoot141
01/4/2014
18:38
Be afraid, very afraid if you have jumped ship here....impo

The CEO didn't make the statement about "compelling reasons to be first to market" for filling a page!

dyor......today was very significant.

jimmyloser
01/4/2014
18:14
Now for the next leg, traders will pour in tomorrow IMO and back up to test the 30 again. Nice 50% for traders in the short term, but much greater for the lti's
big7ime
01/4/2014
12:00
Nice bit of Blue at last guys..:0))
cube boss
01/4/2014
11:45
My word we have a tint of blue! Here's an interesting thought. What if "management" were sat on a major RNS that menat they had significant insider knowledge. Would that preclude them from buying?
audigger
01/4/2014
08:22
This really needs T H to put his money were the companies mouth is, i find it a tad worrying that he still has not bought IF the prospects look so good I still hold but only just i need to see a commitment to keep SOON
mykai
31/3/2014
15:26
The chart is starting to look a bit ill. I think 18.4 is key. If we fall through that then I'm out! Here's hoping we bounce!
audigger
31/3/2014
13:05
hello barefoot slight of topic good set of results at inl dissapointing reaction though
sigora
31/3/2014
13:02
Saturn. I'm afraid it was that straight forward we would all be rich. From a technical perspective it depends where the share price finds support as shares tend do go up in stages and not a straight line. Next leg up or not will be quite important. However that aside the company, partnerships and products look good for the future. i tend to use the charts for entry and exist points and to establish where support/resistance is (market sentiment).
barefoot141
31/3/2014
12:50
I bought some of these shares on the basis of that great rise in the share price on the chart,but then it collapsed.

Just goes to show you cannot trust charts or their indicators.

saturn5
31/3/2014
09:16
Morning guys, very quiet here today, think it's settled for a while.:0)
cube boss
30/3/2014
13:08
"The combination of Endo and Paladin Labs accelerates Endo's transformation into a leading global specialty healthcare company and establishes a platform for additional strategic acquisitions," said Rajiv De Silva, president and chief executive officer of Endo. "Endo will continue with a sharp strategic focus, lean operating model and improved execution of core businesses.



Strategic acquisitions will also continue to play a key role in maximizing our growth potential and creating value for Endo International shareholders."

jimmyloser
29/3/2014
17:01
apparently we are forecast to more than double fy to over £1.1million after "reassuring" interims.
jimmyloser
29/3/2014
16:30
Afternoon all:
If you pop down to W H Smiths this weekend and browse a copy of Shares Magazine then you will find in the latest issue 2 brief mentions of Circassia and one of Allergy Therapeutics.

algernon2
29/3/2014
09:38
well, well, well.! Our Canadian partner swallowed up by a whale of a business>
Endo.

jimmyloser
28/3/2014
16:56
2533 - agree, just keep this board to AGY please
jimmyloser
Chat Pages: Latest  116  115  114  113  112  111  110  109  108  107  106  105  Older

Your Recent History

Delayed Upgrade Clock